scholarly journals In vitro Effect of Radiofrequency on hsp70 Gene Expression and Immune-effector Cells of Birds

Author(s):  
Pradip Kumar Das
2008 ◽  
Vol 14 (18) ◽  
pp. 5900-5906 ◽  
Author(s):  
Jason M. Zimmerer ◽  
Gregory B. Lesinski ◽  
Amy S. Ruppert ◽  
Michael D. Radmacher ◽  
Carl Noble ◽  
...  

1997 ◽  
Vol 9 (4) ◽  
pp. 245-249
Author(s):  
Guoyou Chen ◽  
Xuetao Cao ◽  
Hong Lei ◽  
Long He ◽  
Zhengfang Zhou

2021 ◽  
Vol 7 (5) ◽  
pp. 1811-1828
Author(s):  
Youqing Huang ◽  
Yong Zhong ◽  
Chunhui Qin ◽  
Hao Wang

Adaptive therapy using immune effector cells engineered by means of chimeric antigen receptors (CAR) has risen as a hopeful cancer management option. Despite their unprecedented success in haematological malignancies, CAR-modified T cells have shown limited efficacy in solid tumours, as the tumor’s immune-suppressive microenvironment inhibits CAR-modified immune effector cells’ functionality by different pathways, counting checkpoint receptor ligands expression like PD-L1 & recruitment tregs like suppressive immune cells. Receptor of epidermal growth factor (EGFR) could be the target of a ll-generation Chimeric antigen receptor T cellshat was transduced to NK-92 cell. In our research, we examined the antitumor efficacy of EGFR specific NK-92 (CAR-NK-92) cells using a xenograft mice model & in conjunction with tyrosine kinase inhibitor cabozantinib. We discovered that EGFR positive renal carcinoma cells (RCC) 786-0 and ACHN may specifically detect and activate CAR_NK_92 cells. They also displayed particular cytotoxicity against RCC in in vitro & in vivo models. Furthermore, we discovered that cabozantinib improves RCC-specific cytotoxicity by enhancing the expression of EGFR while reducing PD-L1 expression in RCC. Our research shows that CAR_NK_92 cells possess anti cancer therapeutic potential for EGFR-positive tumour cells, and that cabozantinib can boost CAR_NK_92 cell cytotoxicity when treated together.


2012 ◽  
Vol 13 (1) ◽  
Author(s):  
Claudie Hooper ◽  
Ricardo Sainz-Fuertes ◽  
Steven Lynham ◽  
Abdul Hye ◽  
Richard Killick ◽  
...  

Abstract Background Microglia, the immune effector cells of the CNS and the signaling molecule Wnt, both play critical roles in neurodevelopment and neurological disease. Here we describe the inducible release of exosomes from primary cultured rat microglia following treatment with recombinant carrier-free Wnt3a. Results Wnt3a was internalised into microglia, being detectable in early endosomes, and secreted in exosomes through a GSK3-independent mechanism. Electron microscopy demonstrated that exosomes were elliptical, electron-dense (100 nm) vesicles that coalesced with time in vitro. In contrast to microglia, primary cortical neurons released exosomes constitutively and the quantity of exosomes released was not altered by Wnt3a treatment. The proteomic profile of the microglial-derived exosomes was characterised using liquid chromatography-tandem mass spectrometry (LC/MS/MS) and the vesicles were found to be associated with proteins involved in cellular architecture, metabolism, protein synthesis and protein degradation including β-actin, glyceraldehyde-3-phosphate dehydrogenase, ribosomal subunits and ubiquitin (45 proteins in total). Unlike lipopolysaccharide, Wnt3a did not induce a neurotoxic, pro-inflammatory phenotype in primary microglia. Conclusion These findings reveal a novel mechanism through which Wnt3a signals in microglia resulting in the release of exosomes loaded with proteinaceous cargo.


1979 ◽  
Vol 149 (2) ◽  
pp. 507-515 ◽  
Author(s):  
W H McBride ◽  
J B Bard

A variety of adherent sarcoma, carcinoma and normal cells are surrounded in vitro by thick, transparent zones (approximately equal to 9 micron thick) that spleen cells and a variety of other cells and particles cannot penetrate. Seven lymphoblastoid cell lines did not possess such halos. The presence of these halos around adherent fibrosarcoma cells appeared to protect them from lymphocyte-mediated cytolysis. Hyaluronidase treatment, which destroyed the halo and allowed lymphocytes to approach the tumor cell membrane, enhanced the cytotoxic action of immune but not of normal spleen cells. These observations, in addition to highlighting a little-known feature of the cell surface, may also be of general relevance to the in vitro and in vivo killing of tumor cells by immune effector cells.


1971 ◽  
Vol 134 (5) ◽  
pp. 1170-1186 ◽  
Author(s):  
David L. Rosenstreich ◽  
J. Thomas Blake ◽  
Alan S. Rosenthal

Peritoneal exudate lymphocytes from guinea pigs immunized with horse radish peroxidase, dinitrophenyl guinea pig albumin, or ferritin in complete Freund's adjuvant have been shown to be significantly more reactive than other lymphocytes in two in vitro assays of cellular immune function: production of macrophage migration inhibitory factor and antigen-induced lymphocyte proliferation. The enhanced reactivity of peritoneal exudate lymphocytes cannot be accounted for by artifacts introduced by column purification or by the presence of nonlymphoid accessory cells. These observations suggest that the peritoneal exudate lymphocyte pool is a highly enriched source of cellular immune effector cells with specificity directed towards those antigenic determinants to which an animal has been recently exposed.


2011 ◽  
Vol 29 (15_suppl) ◽  
pp. e13031-e13031
Author(s):  
K. Hasegawa ◽  
J. Atz ◽  
K. Fujiwara ◽  
K. Dettmar ◽  
I. Seitz-Merwald ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document